VALIDATION OF A 22-GENE GENOMIC CLASSIFIER IN PATIENTS WITH RECURRENT PROSTATE CANCER
In this ancillary analysis of the RTOG 9601 study, the researchers validated a 22-gene genomic classifier panel as a predictive biomarker for distant metastases in men with recurrent prostate cancer after radical prostatectomy. The final cohort included 352 men, 89.2% of whom were white. Genomic classifier scores in the final cohort were found to be […]
VALIDATION OF A 22-GENE GENOMIC CLASSIFIER IN PATIENTS WITH RECURRENT PROSTATE CANCER Read More »
